large volume parenteral lvp market – Latest Healthcare Research Reports

Uncover key drivers, emerging technologies, and competitive movements shaping the influenza vaccines market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Influenza Vaccines Market In The Period 2029-2034?

The influenza vaccines market has shown robust expansion in recent years. Its valuation is anticipated to rise from $8.5 billion in 2024 to $9.04 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.3%. This historical growth can be linked to factors including pandemic preparedness, public health initiatives, vaccine effectiveness studies, recommendations from healthcare professionals, and global influenza surveillance efforts.

The influenza vaccines market size is projected to experience substantial growth over the coming years. Its value is anticipated to reach $12.13 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.6%. This expansion during the forecast period is attributable to several elements such as climate and environmental factors, improvements in healthcare accessibility, the appearance of new influenza strains, innovation in adjuvants and delivery systems, and increasing healthcare expenditure. Key trends foreseen in this period encompass the wider utilization of mrna vaccine technology, a focus on pediatric immunization, seasonal influenza control measures, enhanced vaccination coverage in developing nations, and the development of tailored vaccination strategies.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

What Strategic Drivers Are Accelerating The Influenza Vaccines Market Expansion?

The increasing occurrences of seasonal influenza are projected to boost the expansion of the influenza vaccine market moving ahead. Seasonal influenza is defined as a respiratory condition resulting from influenza viruses, which commonly spread and lead to infections at particular periods annually, typically during colder seasons. This shift stems from factors such as antigenic drift, the vulnerability of the population, environmental influences, insufficient vaccine coverage, and the absence of widespread vaccination. Influenza vaccines contribute to decreasing the frequency of seasonal influenza by offering protection against the prevalent strains of the virus. As an illustration, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that roughly 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths occurred during the 2022-2023 flu season. Consequently, the increasing incidences of seasonal influenza are fueling the growth of the influenza vaccines market.

What Is The Detailed Segment Distribution Of The Influenza Vaccines Market?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

How Are Global Trends Impacting The Development Of The Influenza Vaccines Market?

The utilization of technologically advanced vaccine production stands as a prominent trend gaining popularity within the influenza vaccine market. Entities operating in the influenza vaccine market are integrating sophisticated vaccine production technologies to sustain their market position. For example, in January 2023, GlaxoSmithKline PLC., a UK-based pharmaceutical and biotechnology company, introduced MAPS – Multiple Antigen Presenting System for vaccine development. This technology presents an innovative method for creating effective vaccines to combat bacteria and viruses. Additionally, this technology is valuable for quickly developing vaccines during an epidemic or pandemic outbreak.

Who Are The Major Stakeholders Operating In The Influenza Vaccines Market?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Influenza Vaccines Market?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

Browse Through More Reports Similar to the Global Influenza Vaccines Market 2025, By The Business Research Company

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Power Generators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report

Ventricular Assist Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795